359 related articles for article (PubMed ID: 30553953)
21. Promotion or inhibition of extracellular vesicle release: Emerging therapeutic opportunities.
Hao Y; Song H; Zhou Z; Chen X; Li H; Zhang Y; Wang J; Ren X; Wang X
J Control Release; 2021 Dec; 340():136-148. PubMed ID: 34695524
[TBL] [Abstract][Full Text] [Related]
22. Role of tumor‑derived extracellular vesicles in cancer progression and their clinical applications (Review).
Qiao F; Pan P; Yan J; Sun J; Zong Y; Wu Z; Lu X; Chen N; Mi R; Ma Y; Ji Y
Int J Oncol; 2019 May; 54(5):1525-1533. PubMed ID: 30864674
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
Chong SY; Lee CK; Huang C; Ou YH; Charles CJ; Richards AM; Neupane YR; Pavon MV; Zharkova O; Pastorin G; Wang JW
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277271
[TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles: intelligent delivery strategies for therapeutic applications.
Pinheiro A; Silva AM; Teixeira JH; Gonçalves RM; Almeida MI; Barbosa MA; Santos SG
J Control Release; 2018 Nov; 289():56-69. PubMed ID: 30261205
[TBL] [Abstract][Full Text] [Related]
25. Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.
Yang L; Patel KD; Rathnam C; Thangam R; Hou Y; Kang H; Lee KB
Small; 2022 Apr; 18(13):e2104783. PubMed ID: 35132796
[TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicles as personalized medicine.
Beetler DJ; Di Florio DN; Bruno KA; Ikezu T; March KL; Cooper LT; Wolfram J; Fairweather D
Mol Aspects Med; 2023 Jun; 91():101155. PubMed ID: 36456416
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology-Inspired Extracellular Vesicles Theranostics for Diagnosis and Therapy of Central Nervous System Diseases.
Tian T; Qiao S; Tannous BA
ACS Appl Mater Interfaces; 2023 Jan; 15(1):182-199. PubMed ID: 35929960
[TBL] [Abstract][Full Text] [Related]
28. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics.
Wu Q; Fu S; Xiao H; Du J; Cheng F; Wan S; Zhu H; Li D; Peng F; Ding X; Wang L
Adv Sci (Weinh); 2023 Jan; 10(3):e2204814. PubMed ID: 36373730
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines.
Kim OY; Lee J; Gho YS
Semin Cell Dev Biol; 2017 Jul; 67():74-82. PubMed ID: 27916566
[TBL] [Abstract][Full Text] [Related]
30. Theranostic extracellular vesicles: a concise review of current imaging technologies and labeling strategies.
Aafreen S; Feng J; Wang W; Liu G
Extracell Vesicles Circ Nucl Acids; 2023 Mar; 4(1):107-132. PubMed ID: 37829171
[TBL] [Abstract][Full Text] [Related]
31. Treg-Derived Extracellular Vesicles: Roles in Diseases and Theranostics.
Wu T; Wang L; Gao C; Jian C; Liu Y; Fu Z; Shi C
Mol Pharm; 2024 Jun; 21(6):2659-2672. PubMed ID: 38695194
[TBL] [Abstract][Full Text] [Related]
32. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities.
Nagelkerke A; Ojansivu M; van der Koog L; Whittaker TE; Cunnane EM; Silva AM; Dekker N; Stevens MM
Adv Drug Deliv Rev; 2021 Aug; 175():113775. PubMed ID: 33872693
[TBL] [Abstract][Full Text] [Related]
34. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
[TBL] [Abstract][Full Text] [Related]
35. PAHs increase the production of extracellular vesicles both in vitro in endothelial cells and in vivo in urines from rats.
Le Goff M; Lagadic-Gossmann D; Latour R; Podechard N; Grova N; Gauffre F; Chevance S; Burel A; Appenzeller BMR; Ulmann L; Sergent O; Le Ferrec E
Environ Pollut; 2019 Dec; 255(Pt 1):113171. PubMed ID: 31539851
[TBL] [Abstract][Full Text] [Related]
36. Targeting Inflammatory Vasculature by Extracellular Vesicles.
Wang S; Dong X; Gao J; Wang Z
AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
[TBL] [Abstract][Full Text] [Related]
37. Technological advances towards extracellular vesicles mass production.
Grangier A; Branchu J; Volatron J; Piffoux M; Gazeau F; Wilhelm C; Silva AKA
Adv Drug Deliv Rev; 2021 Sep; 176():113843. PubMed ID: 34147532
[TBL] [Abstract][Full Text] [Related]
38. Synergistic siRNA Loading of Extracellular Vesicles Enables Functional Delivery into Cells.
Roerig J; Mitrach F; Schmid M; Hause G; Hacker MC; Wölk C; Schulz-Siegmund M
Small Methods; 2022 Dec; 6(12):e2201001. PubMed ID: 36284470
[TBL] [Abstract][Full Text] [Related]
39. Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics.
Roerig J; Schulz-Siegmund M
Small; 2023 Oct; 19(40):e2301763. PubMed ID: 37287374
[TBL] [Abstract][Full Text] [Related]
40. Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders.
Lu B; Ku J; Flojo R; Olson C; Bengford D; Marriott G
Adv Drug Deliv Rev; 2022 Sep; 188():114465. PubMed ID: 35878794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
